15.88USD-2.16%Mkt Cap: 18.49B $P/E: —1d ago
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. …
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Avg
Div Yield
Lower
1M Perf
Avg
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$9.80MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap18.49B $
Enterprise Value30.70B $
Revenue (TTM)14.56B $
Gross Profit5.01B $
Net Income (TTM)-3.51B $
Revenue/Share12.54 USD
Last Price15.88 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees30.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS92556V1061
Valuation
P/E (Trailing)—
P/E (Forward)5.96
PEG0.15
EV/EBITDA7.44
EV/Revenue2.11
P/S1.27
P/B1.26
EPS (TTM)-0.30
EPS (Forward)2.66
52W Range
8.63081% of range17.53
52W High17.53 USD
52W Low8.630 USD
Profitability
Gross Margin35.06%
Oper. Margin6.78%
EBITDA Margin28.33%
Profit Margin-24.58%
ROE-23.89%
ROA-9.45%
Growth
Revenue Growth8.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.32B $
CapEx (TTM)465.10M $
FCF Margin15.37%
FCF Yield12.10%
Net Debt12.21B $
Net Debt/EBITDA2.96
Balance Sheet
Debt/Equity1.00
Current Ratio1.60
Quick Ratio0.90
Book Value/Sh12.59 USD
Cash/Share2.061 USD
Dividends
Fwd Div Rate0.4800 USD
Trail. Div Rate0.4800 USD
Div. Yield3.02%
5Y Avg Yield4.08%
Payout Ratio960.00%
Ex-Div DateMay 22, 2026
Pay DateJun 17, 2026
Splits
Last Split3:2
Split DateOct 9, 2003
Analyst Consensus
Rating—
Target (Mean)17.81 USD
Upside (mean)+12.2%
Target Range12.00 USD – 23.00 USD
$12.00+12.2% to mean$23.00
# Analysts8
Ownership
Shares Out.1.16B
Float1.16B
Insiders0.43%
Institutions87.96%
Short Interest
Short Ratio4.7d
Short % Float3.88%
Short % Out.3.87%
Shares Short45.05M
Short (prev mo.)38.11M
Technical
SMA 5015.90 (-0.1%)
SMA 20013.13 (+21.0%)
Beta0.90
S&P 52W Chg20.05%
Avg Vol (30d)8.54M
Avg Vol (10d)11.02M
Technical Indicators
RSI (14)48.8
MACD0.0251
MACD Signal0.0244
MACD Hist.+0.0007
BB Upper16.56 USD
BB Middle15.94 USD
BB Lower15.32 USD
BB Width7.80%
ATR (14)0.4726 USD
Vol Ratio (20d)1.15x